PAQ Therapeutics scores $30m Series A

PAQ Therapeutics, a biotechnology company, has raised $30 million in Series A financing.

PAQ Therapeutics, a biotechnology company, has raised $30 million in Series A financing. Sherpa Healthcare Partners led the round with participation from Huagai Capital, MSA Capital, and MRL Ventures Fund, Nest.Bio Ventures and Matrix Partners China.

Source: Press Release